-
Mashup Score: 11Day 3 ACCess Points Daily Wrap Up at ACC 24 - 4 day(s) ago
Did you miss ACC? Don’t worry! Watch Drs. Kim Eagle, Dharam Kumbhani, Ajay Kirtane, and myself as we engage in thought-provoking discussions about the latest…
Source: www.youtube.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 4Day 1 ACCess Points Daily Wrap Up at ACC 24 - 9 day(s) ago
I join Drs. Kim Eagle, Dharam Kumbhani, and Ajay Kirtane to debate and discuss the outcomes of the trials presented on day 1 at ACC.24. We delve into AEGIS I…
Source: www.youtube.comCategories: General Medicine News, Expert PicksTweet-
Missed ACC? Catch up on the latest science from #ACC.24! Join me with Drs. Kim Eagle, Dharam Kumbhani, and Ajay Kirtane as we discuss trials like AEGIS II, VICTORION-INITATE, RELIEVE-HF, and STEP-HFpEF Dm. Stay tuned for expert insights! Full Story: https://t.co/cldNSwHqPm https://t.co/qmRgOkBB7T
-
-
Mashup Score: 40webucation.online - 11 day(s) ago
19:00 Uhr | Begrüßung und Moderation PD Dr. Janine Pöss 19:00 – 19:15 Uhr | Herzinsuffizienz Prof. Dr. Rolf Wachter Uniklinikum Leipzig 19:25 – 19:40 Uhr | Interventionelle Kardiologie Prof. Dr. Holger Thiele Herzzentrum Leipzig 19:50 – 20:05 Uhr | Elektrophysiologie PD Dr. Kerstin Bode Herzzentrum Leipzig 20:15 – 20:30 Uhr | Prävention Prof. Dr. Ulrich Laufs Uniklinikum Leipzig 20:40 | Verabschiedung PD Dr. Janine Pöss und Prof. Dr. Holger Thiele Für die Veranstaltung wurden Fortbildungspunkte bei der
Source: webucation.onlineCategories: General Medicine News, CardiologistsTweet-
🌟 Spannende Einblicke vom Leipziger Kardiologengespräch 2024! 🌟 #ACC.24 Kongress-Update im Livestream: https://t.co/2p3y54yhDe Mittwoch 10.04. 19:00 h @Herzmedizin_de @DGK_org @AGIKinterv @JaninePoss @YoungDgk @AGEP_DGK https://t.co/yQkN1Rfv0z
-
-
Mashup Score: 0
Adjuvant mitotane might not be indicated in patients with low-grade, localised adrenocortical carcinoma considering the relatively good prognosis of these patients, and no significant improvement in recurrence-free survival and treatment-associated toxicity in the mitotane group. However, the study was discontinued prematurely due to slow recruitment and cannot rule out an efficacy of treatment.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet-
#Adjuvant #mitotane versus surveillance in low-grade, localised #adrenocortical #carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study https://t.co/Ujp2h9u9hd #adrenal #ACC
-
-
Mashup Score: 0
Recently, a man aged 50 years came to my office. He had received surgery for a right-sided non-functional adrenocortical carcinoma measuring 11 cm in diameter and had been referred to discuss adjuvant treatment. Based on adrenal histology findings, he had a European Network for the Study of Adrenal Tumors (ENS@T) tumour stage II, which means no lymph node metastases, and a [18F]fluorodeoxyglucose-PET scan had ruled out distant metastasis.1 Fortunately, he had undergone oncological tumour resection resulting in complete resection.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet-
Martin Reincke comments on: Good news for patients with #adrenocortical #carcinoma from the ADIUVO trial https://t.co/LDK290bhAr #adrenal #ACC
-
-
Mashup Score: 0Intravascular imaging for PCI gets a big boost from recent studies - 6 month(s) ago
ACC President Hadley Wilson, MD, explains the big impact four late-breaking studies on intravascular imaging may have on revising PCI guidelines.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Video - ACC President Hadley Wilson explains the big impact of 4 late-breaking studies on intravascular imaging may have on PCI guidelines. @HadleyWilsonMD #ACC #PCI #ESC #Cathlab #IVUS #OCT https://t.co/6oJyIfiMQj
-
-
Mashup Score: 1
Recently, a man aged 50 years came to my office. He had received surgery for a right-sided non-functional adrenocortical carcinoma measuring 11 cm in diameter and had been referred to discuss adjuvant treatment. Based on adrenal histology findings, he had a European Network for the Study of Adrenal Tumors (ENS@T) tumour stage II, which means no lymph node metastases, and a [18F]fluorodeoxyglucose-PET scan had ruled out distant metastasis.1 Fortunately, he had undergone oncological tumour resection resulting in complete resection.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet-
Martin Reincke comments on: Good news for patients with #adrenocortical #carcinoma from the #ADIUVO trial https://t.co/LDK290bhAr #adrenal #ACC
-
-
Mashup Score: 0
Adjuvant mitotane might not be indicated in patients with low-grade, localised adrenocortical carcinoma considering the relatively good prognosis of these patients, and no significant improvement in recurrence-free survival and treatment-associated toxicity in the mitotane group. However, the study was discontinued prematurely due to slow recruitment and cannot rule out an efficacy of treatment.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet-
#Adjuvant #mitotane versus surveillance in low-grade, localised #adrenocortical #carcinoma (#ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study https://t.co/Ujp2h9uH6L #adrenal #ACC #OpenAccess
-
-
Mashup Score: 2Accelerating Chest Pain Evaluation with Machine Learning - 7 month(s) ago
Phyllis Thangaraj, MD PhD, Rohan Khera, MD MS; Accelerating Chest Pain Evaluation with Machine Learning, European Heart Journal. Acute Cardiovascular Care, , zu
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet-
In our Editorial, @cards_lab fellow @PhyllisTweets & I discuss ways in which #MachineLearning can enable efficient + safe discharge in low risk chest pain. And what to watch out for. @ESC_Journals #EHJ #ACC 🔗 https://t.co/qDPYwyK58m @YaleMedPSTP @YaleCardiology https://t.co/4ksL7lr24t
-
-
Mashup Score: 6Hospitals still struggling to reach pre-COVID heart attack care thresholds due to pandemic disruption - 7 month(s) ago
NCDR report finds hospitals are seeing improvements but are still struggling to reach pre-COVID treatment thresholds years after pandemic precautions upended longstanding processes.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Hospitals are seeing improvements but are still struggling to reach pre-COVID treatment thresholds for STEMI D2B years after pandemic precautions upended longstanding processes. #cardiotwitter #cardiology #STEMI #COVID #SARSCoV2 #ACC #NCDR https://t.co/Pwmj8gGuDl
-
Did you miss ACC? Don't worry! Watch Drs. Eagle, Kumbhani, Kirtane, and myself as we discuss about the latest trial results from day 3 at #ACC.24. From TARGET BP I to DEDICATE DZHK6 and FULL REVASC, catch up on all the scientific insights now! Full Story: https://t.co/BmhM1FFQvM https://t.co/4GmRtLdaJW